image sourced from original article at Israel is advancing bioconvergence as a new engine of economic growth, expanding beyond health care into food, agriculture, industry, energy and environmental applications. A midterm government report highlights significant investment in research infrastructure, companies, workforce development and regulatory frameworks under the National Bioconvergence Program.
The program’s first phase, running from 2023 to 2027, is backed by approximately 548.5 million shekels, or about 145 million dollars. Led by a partnership of key government bodies spanning innovation, science, defense, health and finance, the initiative follows recommendations from the Carmi Committee, which called for direct state intervention to build a globally competitive, multidisciplinary ecosystem.
